#BioRxiv

Amy Proal, PhD

microbeminded2

This is an incredibly important preprint to inform #LongCovid. Among many analyses, the team recruited 4 patients w/ prolonged + recurrent olfactory function loss after #COVID-19 (time from first COVID-19

Jessica Hullman

JessicaHullman

Since there was interest in how I addressed this question, here's a thread on what I said in class. TLDR: if you're operating under certain narrow assumptions about what data

Julien Potet

julienpotet

1/ Short thread on #nelfinavir for #COVID19. Among #HIV protease inhibitors, nelfinavir is actually the most promising one, based on pre-clinical data. https://www.mdpi.com/1999-4915/12/6/642https://onlinelibrary.wiley.com/doi/full/10.1002/

Kevin R Burgio PhD

KRBurgio

Today's #ParrotOTD is the Carolina Parakeet, the species I have studied the most! They were the US's only endemic parrot species, surviving through blisteringly cold winters in the midwest. Much

Hannah Haberkern

HannahHaberkern

Let’s start the New Year with a tour of the fly central complex! Read on to learn about circuit motifs that may help insects with integrating diverse sensory information, construct

Deepti Gurdasani

dgurdasani1

My thoughts on the govt announcement yesterday regarding a new viral strain potentially driving an increase in cases in London. The claim, at least from listening to the daily briefing

Bloom Lab

jbloom_lab

We mapped all #SARSCoV2 mutations escaping key antibodies used to treat #COVID19 (https://www.biorxiv.org/content/10.1101/2020.11.30.405472v1). Surprising observations: one amino-acid mutation escapes *both* antibodies in @Regeneron cocktai

Neeltje van Doremalen

DrNeeltje

Manuscript Alert!! Thread. In our latest manuscript, we look at the efficacy of intranasal vaccination with the Oxford/Astrazeneca vaccine, in both hamsters and rhesus macaques:https://www.biorxiv.org/content/10.1101/2021.01.09.426058v1.art

Yasuhiro Arimura

ArmrYshr

Hey chromatin folks! I am incredibly excited to share my first preprint paper and first paper from the Funabiki lab with you! "Near-atomic resolution nucleosome structures and their variations in

David Ascher

DrDavidAscher

Excited that COVID-3D has been published in Nature Genetics. This is a great piece of work from the group, but led especially @steffportelli @carlosmr12 @elston_neil and Moshe. This work was

Katalina Bobowik

KatalinaBobowik

I'm very excited to share the results of our new paper, now available on Biorxiv: https://biorxiv.org/cgi/content/short/2021.01.07.425684v1. Below is a thread of the main resultshttps://twitter.com/biorxivpreprint/status/134762719313285

Jack Ashby

JackDAshby

There's been gentle criticism of the new #thylacine study (where @BraveNewClimate concludes #thylacines probably survived to the 90s) as it's based eye-witness accounts, which are obviously unreliable.Here's a little thread

Joel Boerckel

jboerckel

Our latest preprint, from Anna McDermott & @EmilyEastburn1 in the lab, is live today! "Effects of chondrogenic priming duration on mechanoregulation of engineered cartilage anlagen"https://www.biorxiv.org/content/10.1101/2020.

Lina Leon

LinaMLion

If you need more anti-CRISPRs in your life, this is the paper for you! I worked on this study with a wonderful team: @AdairLBorges @jenzyy_97 @allysonparkk and @joeBondyDenomy. We discovered

Bjørn Panyella Pedersen

BjornPPedersen

New preprint on the fascinating KdpFABC K+ pump. Lead by grad student Marie Sweet and the Stokes group at NYU (@SkirballNYUSoM), we are proud to be part of this comprehensive

Lonni Besançon

lonnibesancon

The #COVID19 pandemic has led to a number of questionable research practices which a full adherence to #openscience could have avoided. Researchers, co-sign if you agree.Article: https://www.biorxiv.org/content/10.1101/2020.08.13.249847v1Si

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.